Our Bureau
Chicago, IL
LUNGevity, the nation’s leading lung cancer research foundation, welcomes Dr. Sandip Patel as new experts to its Scientific Advisory Board to help guide their programs to transform how people are diagnosed and live with lung cancer.
“We are honored to announce Dr. Sandip Patel as the newest members of LUNGevity’s Scientific Advisory Board,” said Charles Rudin, MD, PhD, deputy director of the Cancer Center at Memorial Sloan Kettering and chair of LUNGevity’s Scientific Advisory Board. As LUNGevity continues to expand its research investment, LUNGevity is eager to have Dr. Patel onboard to guide LUNGevity on key initiatives that will lead to true improvements for people with this disease.
Dr. Patel, MD, is a professor at University of California, San Diego, and a top medical oncologist focusing on early-phase clinical trials of immunotherapy and thoracic oncology.
“Having seen the impact of lung cancer on our patients and families, I am honored to be joining LUNGevity’s Scientific Advisory Board where we play an increasingly important role in funding research in the leading cause of cancer-related death worldwide,” said Dr. Patel. “From screening to targeted therapeutic resistance, and from bench to bedside, I am eager to contribute to LUNGevity’s mission in reducing the burden of lung cancer in our communities and worldwide.”
After earning his medical degree at Baylor College of Medicine while conducting research at MD Anderson Cancer Center, Dr. Patel completed a residency in internal medicine at UCLA Medical Center and a fellowship in medical oncology and hematology at Duke University Medical Center. He is triple-board-certified in internal medicine, medical oncology, and hematology. In addition, he was named a “Top Doc” in the most recent San Diego Magazine “Physicians of Exceptional Excellence” survey.
Dr. Patel is the leader of the Experimental Therapeutics (Phase 1) Program and co-leader of the Solid Tumor Therapeutics Program at UCSD Moores Cancer Center. He is deputy director of the Sanford Stem Cell Clinical Institute, as well as co-leader of the NRG Developmental Therapeutics Committee and medical director of clinical research informatics at UCSD.
